Sesame is offering compounded semaglutide — the active ingredient in Wegovy and Ozempic — to help users access obesity and diabetes treatments amid shortages.
https://www.cnbc.com/2024/08/21/sesame-to-offer-compounded-wegovy-through-weight-loss-program.html